Document is current
Any future updates will be listed below
-
Authors
Vogel, Rachel I.
Stenzel, Ashley E.
Lee, Heewon
Hunter-Schlichting, DeVon
Wesley, Erin
Uppendahl, Locke D.
Geller, Melissa A.
Nelson, Heather H.
-
Funding
Funding for this research was provided by:
Department of Defense Ovarian Cancer Research Program (OC180392 W81XWH-19-1-0013, OC180211 W81XWH-19-1-0014)
American Cancer Society (124166-IRG-58-001-55-IRG56)
- License Information
-
More Information
Article History
Received: 12 May 2023
Accepted: 25 October 2023
First Online: 3 November 2023
Declarations
:
: These data were presented in part by RIV as posters at the Society of Gynecologic Oncology Annual Meeting, Phoenix, AZ, March 18?21, 2022 and the Rivkin Center and the American Association for Cancer Research 14th Biennial Virtual Ovarian Cancer Research Seminar Series, September 2022.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of University of Minnesota (1610M96942; 1605M87302). Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The authors declare no competing interests.
